HSBC Holdings
CUE icon

HSBC Holdings’s Cue Biopharma CUE Stock Holding History

HSBC Holdings’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-455
Closed -$170K – 2799
2020
Q4 		$170K Buy
455
+23
+5% +$9.19K ﹤0.01% 2854
2020
Q3 		$201K Buy
432
+4
+0.9% +$2.31K ﹤0.01% 2471
2020
Q2 		$315K Buy
+428
New +$310K ﹤0.01% 2096
2020
Q1 		– Sell
-1,009
Closed -$473K – 2748
2019
Q4 		$473K Sell
1,009
-1,263
-56% -$397K ﹤0.01% 2252
2019
Q3 		$574K Buy
+2,272
New +$546K ﹤0.01% 2253

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return

HSBC Holdings's CUE Position: Q1 2021 in Review

HSBC Holdings sold out of Cue Biopharma (CUE) in Q1 2021, closing a stake of 455 shares — an estimated $170K sold.

HSBC Holdings first reported a position in CUE in Q3 2019 and held it in 5 quarters. The position peaked at $574K in Q3 2019. 89 funds tracked by Wall St. Rank hold CUE as of Q1 2021.

  • HSBC Holdings reported no remaining Cue Biopharma position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 455 Cue Biopharma shares in Q1 2021, an estimated $170K.
  • HSBC Holdings first reported a position in Cue Biopharma in Q3 2019 and held it in 5 quarters.
  • HSBC Holdings's Cue Biopharma position peaked at $574K in Q3 2019.
  • 89 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.